Skip to content

A prospective study of the outcomes of Descemet membrane endothelial keratoplasty (DMEK)

A prospective study of the outcomes of Descemet membrane endothelial keratoplasty (DMEK) - A prospective study of Descemet membrane endothelial keratoplasty (DMEK)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027586
Enrollment
100
Registered
2017-06-01
Start date
2014-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bullous keratopathy

Interventions

None listed

Sponsors

Department of Ophthalmology, Yokohama Minami Kyosai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Bullous keratopathy, Fuchs endothelial dystrophy, pseudo-exfoliation syndrome, birth injury, corneal endothelitis, eye with low corneal endothelial cell density, because of unknown factors

Exclusion criteria

Exclusion criteria: patient who dont agree with the research

Design outcomes

Primary

MeasureTime frame
Visual acuity(logMAR),Endothelial Cell Density(ECD), Central Corneal Thickness(CCT),High-order Abberattions(HOAs), and VFQ-25 were assessed preoperatively, and at1,3, 6 months, 1, 2, 3, 4, and 5 years postoperatively.

Secondary

MeasureTime frame
Central retinal thickness, Cystoid macula edema(CME), posteior synechia, iris abnormality, operative time, graft unfolding timewere assessed preoperatively, and at1,3, 6 months, 1, 2, 3, 4, and 5 years postoperatively.

Countries

Japan

Contacts

Public ContactTakahiko Hayashi

Medical Techno Department of Ophthalmology

takamed@gmail.com+817038502167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026